MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Effectiveness of bilateral pallidal deep brain stimulation in a patient with dystonia associated to neurodegenerative ataxia: Follow-up to 18 months

    P.A. Millan, J.M. Cardenas (Cali, Colombia)

    Objective: CASE REPORT Background: The dystonia like others movement disorder may be included in neurodegenerative ataxia syndrome, in addition to cerebellar dysfunction. The pallidal stimulation…
  • 2016 International Congress

    Ataxic gait in subjects with essential tremor and thalamic neurostimulation is caused by posteromedial current spread in the (sub)thalamic area

    M.M. Reich, J. Brumberg, N. Pozzi, M. Åström, R. Nijlunsing, T. Musacchio, F. Steigerwald, G. Marotta, A. Buck, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: We aimed to disentangle a putative role of bilateral thalamic DBS in developing gait-ataxia in subjects with ET. Background: In ET patients with DBS,…
  • 2016 International Congress

    Targeting TLR4 for disease modification in multiple system atrophy: Experimental evidence

    S. Venezia, V. Refolo, N. Stefanova (Innsbruck, Austria)

    Objective: To assess the efficacy of toll-like receptor 4(TLR4) agonists to ameliorate the functional and neuropathological phenotype of a transgenic mouse model of multiple system…
  • 2016 International Congress

    Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

    E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

    Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…
  • 2016 International Congress

    Dementia in Parkinson’s disease is associated with increased diffusivity in amygdala and external capsule

    A. Umemura, T. Oeda, K. Yamamoto, M. Kohsaka, S. Tomita, K. Park, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: To identify which regions are associated with dementia in Parkinson's disease (PD) brains. Background: Dementia is common in advanced PD and its early development…
  • 2016 International Congress

    Clinical and MRI-characteristics of drug-induced parkinsonism in Uzbekistan

    A. Umarov, A. Prokhorova, G. Rakhimbaeva, K. Mirzaeva, N. Tuychibaeva (Tashkent, Uzbekistan)

    Objective: To establish clinical and MRI morphometric differences between Parkinson's disease (PD) and Drug-induced parkinsonism (DP). Background: DP – is the most known side effect…
  • 2016 International Congress

    Muscle ceroid-lipofuscine-like deposits in a patient with FTD due to a progranulin mutation

    R. Terlizzi, M.L. Valentino, A. Bartoletti-Stella, M. Columbaro, S. Piras, P. Martinelli, P. Parchi, S. Capellari (Bologna, Italy)

    Objective: We report a case of a Cortical Basal Syndrome (CBS) due to heterozygous Granulin (GRN) mutation who develops a lysosomal storage pathology characterized by…
  • 2016 International Congress

    Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?

    M. Schuberth, G. Nübling, J. Hauer, T. Marquardt, S. Lorenzl (München, Germany)

    Objective: The aim of the study is to establish chitotriosidase and oxysterols as a biomarker for atypical Parkinsonian syndromes in order to make a distinction…
  • 2016 International Congress

    Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia

    S. Kurcova, K. Mensikova, L. Tuckova, J. Ehrmann, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To report two cases of patients with unusual manifestation of pathologically confirmed PSP. Background: Based on the results of recent multicenter clinical-pathological studies, it…
  • 2016 International Congress

    Defining the pathology underlying cortico-basal syndrome: A European study

    R.C. Lamb, M.C. Darvell, J.D.S. Woodside, J.D. Rohrer, A.J. Lees, H.R. Morris (London, United Kingdom)

    Objective: To understand how clinical and biological features can help us define and explain the varying pathology that underlies corticobasal syndrome (CBS). Background: Corticobasal degeneration…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley